Formulation in treatment of leukemia, comprises a pharmaceutically active component and a surface-modified liposome encapsulating the pharmaceutically active component
2023-09-26
专利权人BIRLA INST TECHNOLOGY & SCI PILANI (BIRL-Non-standard) ; INDIAN COUNCIL MEDICAL RES (INCO-Non-standard)
申请日期2023-09-26
专利号IN202311064593-A
成果简介NOVELTY - Formulation comprises a pharmaceutically active component and a surface-modified liposome encapsulating the pharmaceutically active component. USE - Formulation in treatment of leukemia. No biological data given. ADVANTAGE - The formulation effectively preserve the structural integrity and physicochemical properties of the vesicles over the duration of the study, and shows better therapeutic benefits with low toxicity. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for method of preparation of a formulation used in treatment of leukemia, which involves: (i) dissolving a pharmaceutical active component in an equivolume mixture of methanol and chloroform at a temperature ranging from 40 to 70℃ to obtain a clear solution; (ii) adding lipids into the clear solution and stirring the solution for a duration of 2-6 minutes to obtain an organic solution; (iii) evaporating the solvent from the organic solution of step (ii) to obtain a lipid thin film; (iv) rehydrating the obtained thin film using phosphate-buffered saline (PBS) of pH 7.4 to form a liposome; (v) subjecting the liposome to sonication at an amplitude of 30% to 45% for 4-10 minutes to obtain a liposomal suspension; and (vi) filtering the liposomal suspension obtained, followed by lyophilization using a cryoprotectant to obtain the drug-loaded formulation.
IPC 分类号A61K-031/4745 ; A61K-031/496 ; A61K-038/50 ; A61K-047/69 ; A61K-009/127 ; A61K-009/133 ; A61P-035/00 ; A61P-035/02
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20249
专题中国科学院新疆生态与地理研究所
作者单位
1.BIRLA INST TECHNOLOGY & SCI PILANI (BIRL-Non-standard)
2.INDIAN COUNCIL MEDICAL RES (INCO-Non-standard)
推荐引用方式
GB/T 7714
CHAURASIYA A,PATRA P. Formulation in treatment of leukemia, comprises a pharmaceutically active component and a surface-modified liposome encapsulating the pharmaceutically active component. IN202311064593-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。